New opportunities in pancreatic cancer: RAS inhibitors, highly complex surgery and integrated care
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is taking part in the development of new RAS inhibi...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is taking part in the development of new RAS inhibi...
The selected projects will address challenges related to liver diseases, haematopoietic transplantation, work-related cancers, healthy ageing, colo...
On World Cancer Research Day, 24 September, we would like to highlight some of the most significant advances made over the past year by Clínic-IDIB...
The EPoS II study, published in the New England Journal of Medicine, provides new evidence on the follow-up of patients after the removal of high-r...
A study led by the professionals from the Clínic-IDIBAPS has analysed the factors that explain why some people do not undergo a colonoscopy after o...
